CLINICAL_TRIALS
trial_result
· 2024-05-23
Clinical Trial Update: Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating pevonedistat alone and with chemotherapy in mesothelioma has been terminated, with results posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mesothelioma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-05-23